Eczema Free Forever™

Pfizer’s Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status – FiercePharma


FiercePharma
Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status
FiercePharma
Pfizer's first campaign for its new eczema drug Eucrisa kicks off with an appealing, kid-friendly "nose to toes" TV ad, but behind the lighthearted wordplay is the potential to capitalize on its first-to-market status. Pfizer's Eucrisa is an early

eczema – Google News

Eczema Free Forever™